Abstract
Objective
To test the expression of HER4 in non-small cell lung cancer (NSCLC) and elucidate the relationship between its over-expression and the clinical pathology of NSCLC.
Methods
70 cases of paraffin-embedded tissues from informative NSCLC were tested for the expression of HER4 by means of immunohistochemical assay.
Results
HER4 were overexpressed in NSCLC in 91.4%. The overexpression of HER4 correlated only with the lymph node metastasis, TNM staging and survival after operation.
Conclusion
ErbB4 is one of the genes to regulate the growth of NSCLC in advanced stages and artificial interference of the overexpression of HER4 in NSCLC might be a good way for the treatment of NSCLC in advanced stages.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Xing CP, Liu B, Dong L. The criterion of immunohistochemistry. Chin J Pathol (Chinese), 2001, 30: 318.
Jacobs TW, Gown AM, Yaziji H, et al. Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system. J Clin Oncol, 1999, 17: 1983–1987.
Lai C, Lemke G. An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous system. Neuron, 1991, 6: 691–704.
Plowman GD, Culouscou JM, Whitney GS, et al. Ligand-specific activation of HER4/P180erbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci USA, 1993, 90: 1746–1750.
Srinivasan R, Poulsom R, Hurst HC, et al. Expression of the c-erbB4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types. J Pathol, 1998, 185: 236–245.
Bonnet H, Filhol O, Truchet I, et al. Fibroblast growth factor-2 binds to the regulatory beta subunit of CK2 and directly stimulates CK2 activity toward nucleolin. J Biol Chem, 1996, 271: 24781–24787.
Li W, Park JW, Nuijens A, et al. Heregulin is rapidly translocated to the nucleus and its transprot is correlated with c-myc induction in breast cancer cells. Oncogene, 1996, 12: 2473–2477.
al Moustafa AE, Alaoui-Jamali M, Paterson J, et al. Expression of P185erbB-2, P160ERBb-3, P180erbB-4, and Heregulin alpha in human normal bronchial epithelial and lung cancer cell lines. Anticancer Res, 1999, 19: 481–486.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by a grant from the Ningbo Health Bureau of Zhejiang province (No. 2002057).
Rights and permissions
About this article
Cite this article
Deng, Z., Yu, W., Hu, G. et al. A study on the expression of erbB4/HER4 in non-small cell lung cancer. Chin. -Ger. J. Clin. Oncol. 7, 75–77 (2008). https://doi.org/10.1007/s10330-007-0149-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10330-007-0149-6